K171605

Substantially Equivalent

Elecsys CA 15-3 II

Applicant: Roche Diagnostics
Product code: MOI
Advisory panel: Immunology
Date received: 2017-06-01
Decision date: 2018-02-20
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.